Zhongchao (ZCMD)
Providing medical education and patient-management services for China’s healthcare ecosystem.
Something off on this page? Send us feedback.
Provides professional medical education and patient-management services in China, earning fixed-fee project revenue from pharmaceutical and not-for-profit clients. The Nasdaq-listed Cayman parent relies on contractual arrangements to consolidate its PRC operating entities.
Operates MDMOOC, a China-focused professional medical-education platform, alongside Zhongxin Health patient-management services. Its medical education includes specialist courses, clinical cases, articles, onsite training and conferences; patient-aid work supports prescription applications, medication tracking and drug delivery for selected cancer, rare-disease and major-disease programs.
Generates service revenue through fixed-fee projects commissioned chiefly by pharmaceutical companies and not-for-profit organizations. Healthcare professionals and patients use the resulting digital content and services, with operations and revenue-generating assets concentrated in China. The Nasdaq-listed Cayman parent consolidates its PRC operating business through contractual VIE arrangements rather than direct equity ownership.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $13.9M · Total debt $26.1K · Total assets $24.3M · Shareholders' equity $18.6M
- Revenue
- $5.8M
- Operating income
- −$5.3M
- Net income
- −$5.3M
No dividends on record.
| Institutions2 holders · as of Mar 31, 2026 | 0.12% | 129 ADS | |
| Insiders5 holders · as of Jul 22, 2026 | 65.13% | 67.9K ADS | |
| Otherremainder | 34.75% | 36.2K ADS |
104.2K ADS (1 ADS = 40 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Dec 2024 annual report; nothing newer is on file here.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Weiguang YangInsiderdirector, 10 percent owner, officer: Chief Executive Officer | 65.13% | 2.50M A ordinary · 212,702 B ordinary | Form 4filed Jul 22, 2026 ↗ |
XTX Topco LtdInstitution | 0.12% | 11,866 A ADS | 13Fas of Mar 31, 2026 |
Tower Research Capital LLC (TRC)Institution | 0.00% | 110 A ADS | 13Fas of Mar 31, 2026 |
Pei XuInsiderdirector, officer: Chief Financial Officer | 0.00% | 39 A ordinary | Form 4filed Mar 18, 2026 ↗ |
John Conrad GeneralInsiderdirector | 0.00% | 21 A ordinary | Form 4filed Mar 19, 2026 ↗ |
| See all 8 → | |||
13F — a manager's quarterly holdings · Form 4 — an insider's transaction report
Insider tradesForm 4
No open-market trades in the last 12 months.
Not reported.